Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/springer-journals/ranolazine-clinical-applications-and-therapeutic-basis-Sx10Y77j3d
References (96)
-
Ronald Miles, R. Passman, D. Murdock (2011)
Comparison of effectiveness and safety of ranolazine versus amiodarone for preventing atrial fibrillation after coronary artery bypass grafting.The American journal of cardiology, 108 5
-
Lin Wu, J. Shryock, Yejia Song, L. Belardinelli (2006)
An Increase in Late Sodium Current Potentiates the Proarrhythmic Activities of Low-Risk QT-Prolonging Drugs in Female Rabbit HeartsJournal of Pharmacology and Experimental Therapeutics, 316
-
W. Clusin (2003)
Calcium and Cardiac Arrhythmias: DADs, EADs, and AlternansCritical Reviews in Clinical Laboratory Sciences, 40
-
A. Macinnes, D. Fairman, P. Binding, J. Rhodes, Michael Wyatt, A. Phelan, P. Haddock, E. Karran (2003)
The Antianginal Agent Trimetazidine Does Not Exert Its Functional Benefit via Inhibition of Mitochondrial Long-Chain 3-Ketoacyl Coenzyme A ThiolaseCirculation Research: Journal of the American Heart Association, 93
-
James McCormack, R. Barr, Andrew Wolff, G. Lopaschuk (1996)
Ranolazine stimulates glucose oxidation in normoxic, ischemic, and reperfused ischemic rat hearts.Circulation, 93 1
-
Kirsten Hoyer, Yejia Song, Desuo Wang, D. Phan, J. Balschi, J. Ingwall, L. Belardinelli, J. Shryock (2011)
Reducing the Late Sodium Current Improves Cardiac Function during Sodium Pump Inhibition by OuabainJournal of Pharmacology and Experimental Therapeutics, 337
-
K. Abozguia, K. Clarke, Leong Lee, M. Frenneaux (2006)
Modification of myocardial substrate use as a therapy for heart failureNature Clinical Practice Cardiovascular Medicine, 3
-
D. Murdock, J. Reiffel, J. Kaliebe, G. Larrain (2010)
The Conversion of Paroxysmal or Initial Onset Atrial Fibrillation with Oral Ranolazine: Implications for a New "Pill-In-Pocket" Approach in Structural Heart DiseaseJournal of Atrial Fibrillation, 2
-
M. Ortiz (1985)
Slow currents through single sodium channels of the adult rat heartThe Journal of General Physiology, 86
-
A. Dhalla, Wei-qun Wang, Joan Dow, J. Shryock, L. Belardinelli, A. Bhandari, R. Kloner (2009)
Ranolazine, an antianginal agent, markedly reduces ventricular arrhythmias induced by ischemia and ischemia-reperfusion.American journal of physiology. Heart and circulatory physiology, 297 5
-
Y. Ju, D. Saint, P. Gage (1992)
Effects of lignocaine and quinidine on the persistent sodium current in rat ventricular myocytesBritish Journal of Pharmacology, 107
-
R. Létienne, B. Vié, A. Puech, S. Vieu, B. Grand, G. John (2001)
Evidence that ranolazine behaves as a weak beta1- and beta2-adrenoceptor antagonist in the rat [correction of cat] cardiovascular system.Naunyn-Schmiedeberg's archives of pharmacology, 363 4
-
M. Jerling, H. Abdallah (2005)
Effect of renal impairment on multiple‐dose pharmacokinetics of extended‐release ranolazineClinical Pharmacology & Therapeutics, 78
-
V. Roger, A. Go, D. Lloyd‐Jones, R. Adams, J. Berry, T. Brown, M. Carnethon, S. Dai, G. Simone, E. Ford, C. Fox, H. Fullerton, C. Gillespie, K. Greenlund, S. Hailpern, J. Heit, P. Ho, V. Howard, B. Kissela, S. Kittner, D. Lackland, J. Lichtman, L. Lisabeth, D. Makuc, G. Marcus, A. Marelli, D. Matchar, M. McDermott, J. Meigs, C. Moy, D. Mozaffarian, M. Mussolino, G. Nichol, N. Paynter, W. Rosamond, P. Sorlie, R. Stafford, T. Turan, M. Turner, N. Wong, J. Wylie-Rosett (2011)
Heart disease and stroke statistics--2011 update: a report from the American Heart Association.Circulation, 123 4
-
P. Stone, B. Chaitman, K. Stocke, J. Sano, A. Devault, G. Koch (2010)
The anti-ischemic mechanism of action of ranolazine in stable ischemic heart disease.Journal of the American College of Cardiology, 56 12
-
Y. Ju, D. Saint, P. Gage (1996)
Hypoxia increases persistent sodium current in rat ventricular myocytes.The Journal of Physiology, 497
-
M. Koren, M. Crager, M. Sweeney (2007)
Long-term safety of a novel antianginal agent in patients with severe chronic stable angina: the Ranolazine Open Label Experience (ROLE).Journal of the American College of Cardiology, 49 10
-
S. Giri, C. White, A. Dunn, K. Felton, L. Freeman-Bosco, P. Reddy, J. Tsikouris, Heather Wilcox, J. Kluger (2001)
Oral amiodarone for prevention of atrial fibrillation after open heart surgery, the Atrial Fibrillation Suppression Trial (AFIST): a randomised placebo-controlled trialThe Lancet, 357
-
BM Scirica, DA Morrow, H Hod, SA Murphy, L Belardinelli, CM Hedgepeth (2007)
Effect of ranolazine, an antianginal agent with novel electrophysiological properties, on the incidence of arrhythmias in patients with non ST-segment elevation acute coronary syndrome: results from the metabolic efficiency with ranolazine for less ischemia in non st-elevation acute coronary syndrome thrombolysis in myocardial infarction 36 (MERLIN-TIMI 36) randomized controlled trialCirculation, 116
-
B. Chaitman, S. Skettino, J. Parker, P. Hanley, J. Meluzin, J. Kuch, C. Pepine, Whedy Wang, J. Nelson, David Hébert, A. Wolff (2004)
Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina.Journal of the American College of Cardiology, 43 8
-
S. Siu, Richard Jacoby, R. Phillips, R. Nesto (1993)
Comparative efficacy of nifedipine gastrointestinal therapeutic system versus diltiazem when added to beta blockers in stable angina pectoris.The American journal of cardiology, 71 11
-
G. Gintant, N. Datyner, I. Cohen (1984)
Slow inactivation of a tetrodotoxin-sensitive current in canine cardiac Purkinje fibers.Biophysical journal, 45 3
-
Y. Ning, Wei Zhen, Zhuo Fu, Jenny Jiang, Dongmin Liu, L. Belardinelli, A. Dhalla (2011)
Ranolazine Increases β-Cell Survival and Improves Glucose Homeostasis in Low-Dose Streptozotocin-Induced Diabetes in MiceJournal of Pharmacology and Experimental Therapeutics, 337
-
Jeroen Bax, G. Bleeker, T. Marwick, S. Molhoek, E. Boersma, P. Steendijk, E. Wall, M. Schalij (2004)
Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy.Journal of the American College of Cardiology, 44 9
-
A. Capucci, G. Boriani, G. Botto, T. Lenzi, I. Rubino, C. Falcone, G. Trisolino, S. Casa, N. Binetti, M. Cavazza, M. Sanguinetti, B. Magnani (1994)
Conversion of recent-onset atrial fibrillation by a single oral loading dose of propafenone or flecainide.American Journal of Cardiology, 74
-
U. Thadani, M. Ezekowitz, L. Fenney, Y. Chiang (1994)
Double-blind efficacy and safety study of a novel anti-ischemic agent, ranolazine, versus placebo in patients with chronic stable angina pectoris. Ranolazine Study Group.Circulation, 90 2
-
T. Nieminen, C. Tavares, J. Pegler, L. Belardinelli, R. Verrier (2011)
Ranolazine Injection Into Coronary or Femoral Arteries Exerts Marked, Transient Regional Vasodilation Without Systemic Hypotension in an Intact Porcine ModelCirculation: Cardiovascular Interventions, 4
-
H. Matsumura, A. Hara, H. Hashizume, K. Maruyama, Y. Abiko (1998)
Protective effects of ranolazine, a novel anti-ischemic drug, on the hydrogen peroxide-induced derangements in isolated, perfused rat heart: comparison with dichloroacetate.Japanese journal of pharmacology, 77 1
-
U. Thadani, M. Ezekowitz, L. Fenney, Y. Chiang (1994)
Double‐Blind Efficacy and Safet Study of a Novel Anti‐Ischemic Agent, Ranolazine, Versus Placebo in Patients With Chronic Stable Angina PectorisCirculation, 90
-
B. Gersh (2007)
Optimal Medical Therapy with or without PCI for Stable Coronary DiseaseYearbook of Endocrinology, 2008
-
BM Scirica, E Braunwald, L Belardinelli, CM Hedgepeth, J Spinar, W Wang (2010)
Relationship between nonsustained ventricular tachycardia after non-ST-elevation acute coronary syndrome and sudden cardiac death: observations from the metabolic efficiency with ranolazine for less ischemia in non-ST-elevation acute coronary syndrome-thrombolysis in myocardial infarction 36 (MERLIN-TIMI 36) randomized controlled trialCirculation, 122
-
F. Pelliccia, V. Pasceri, G. Marazzi, G. Rosano, C. Greco, C. Gaudio (2012)
A pilot randomized study of ranolazine for reduction of myocardial damage during elective percutaneous coronary intervention.American heart journal, 163 6
-
S. Sossalla, S. Wagner, E. Rasenack, Hanna Ruff, Sarah Weber, F. Schöndube, T. Tirilomis, G. Tenderich, G. Hasenfuss, L. Belardinelli, L. Maier (2008)
Ranolazine improves diastolic dysfunction in isolated myocardium from failing human hearts--role of late sodium current and intracellular ion accumulation.Journal of molecular and cellular cardiology, 45 1
-
R. Greene, Robert Rangel, Krystal Edwards, Lisa Chastain, S. Brouse, Carlos Alvarez, Laura Collins, E. Brilakis, S. Banerjee (2011)
Ranolazine for the treatment of refractory angina in a veterans population.Cardiovascular revascularization medicine : including molecular interventions, 13 2
-
M. Rousseau, H. Pouleur, G. Cocco, A. Wolff (2005)
Comparative efficacy of ranolazine versus atenolol for chronic angina pectoris.The American journal of cardiology, 95 3
-
Yejia Song, J. Shryock, S. Wagner, L. Maier, L. Belardinelli (2006)
Blocking Late Sodium Current Reduces Hydrogen Peroxide-Induced Arrhythmogenic Activity and Contractile DysfunctionJournal of Pharmacology and Experimental Therapeutics, 318
-
A. Timmis, B. Chaitman, M. Crager (2006)
Effects of ranolazine on exercise tolerance and HbA1c in patients with chronic angina and diabetes.European heart journal, 27 1
-
R. Venkataraman, W. AlJaroudi, L. Belardinelli, J. Heo, A. Iskandrian (2011)
The effect of ranolazine on the vasodilator-induced myocardial perfusion abnormalityJournal of Nuclear Cardiology, 18
-
Smriti Deshmukh, Snehal Patel, E. Pinassi, C. Mindrescu, Eileen Hermance, M. Infantino, J. Coppola, C. Staniloae (2009)
Ranolazine improves endothelial function in patients with stable coronary artery diseaseCoronary Artery Disease, 20
-
D. Murdock, N. Overton, M. Kersten, J. Kaliebe, F. Devecchi (2008)
The effect of ranolazine on maintaining sinus rhythm in patients with resistant atrial fibrillationIndian Pacing and Electrophysiology Journal, 8
-
B. Chaitman, Abhay Laddu (2012)
Stable angina pectoris: antianginal therapies and future directionsNature Reviews Cardiology, 9
-
H. Fraser, L. Belardinelli, Lianguo Wang, P. Light, J. McVeigh, A. Clanachan (2006)
Ranolazine decreases diastolic calcium accumulation caused by ATX-II or ischemia in rat hearts.Journal of molecular and cellular cardiology, 41 6
-
Yong-hu Fang, L. Piao, Z. Hong, P. Toth, G. Marsboom, Peter Bache-Wiig, J. Rehman, S. Archer (2011)
Therapeutic inhibition of fatty acid oxidation in right ventricular hypertrophy: exploiting Randle’s cycleJournal of Molecular Medicine, 90
-
M. Jerling (2006)
Clinical Pharmacokinetics of RanolazineClinical Pharmacokinetics, 45
-
D. Murdock, J. Reiffel, J. Kaliebe, G. Larrain (2010)
THE CONVERSION OF PAROXYSMAL OR INITIAL ONSET ATRIAL FIBRILLATION WITH ORAL RANOLAZINE: IMPLICATIONS FOR “PILL IN THE POCKET” APPROACH IN STRUCTURAL HEART DISEASEJournal of the American College of Cardiology, 55
-
D. Murdock, J. Kaliebe, G. Larrain (2012)
The Use of Ranolazine to Facilitate Electrical Cardioversion in Cardioversion‐Resistant Patients: A Case SeriesPacing and Clinical Electrophysiology, 35
-
Giannini Cristina, P. Sonia, D. Marco, Guarracino Fabio, C. Lorenzo, F. Francesca, Pier Andrea, B. Di (2014)
Integrated reverse left and right ventricular remodelling after MitraClip implantation in functional mitral regurgitation: an echocardiographic studyEuropean Heart Journal, 15
-
(1994)
Ranolazine: antianginal therapy with a novel mechanism: placebo controlled comparison versus atenolol (abstr.) -
R. Venkataraman, Ji Chen, Ernest Garcia, L. Belardinelli, F. Hage, J. Heo, A. Iskandrian (2012)
Effect of ranolazine on left ventricular dyssynchrony in patients with coronary artery disease.The American journal of cardiology, 110 10
-
A. Undrovinas, L. Belardinelli, N. Undrovinas, H. Sabbah (2006)
Ranolazine Improves Abnormal Repolarization and Contraction in Left Ventricular Myocytes of Dogs with Heart Failure by Inhibiting Late Sodium CurrentJournal of Cardiovascular Electrophysiology, 17
-
L. Donck, M. Borgers, F. Verdonck (1993)
Inhibition of sodium and calcium overload pathology in the myocardium: a new cytoprotective principle.Cardiovascular research, 27 3
-
H. Abdallah, M. Jerling (2005)
Effect of Hepatic Impairment on the Multiple‐Dose Pharmacokinetics of Ranolazine Sustained‐Release TabletsThe Journal of Clinical Pharmacology, 45
-
A. Moss, W. Zareba, K. Schwarz, S. Rosero, S. McNitt, Jennifer Robinson (2008)
Ranolazine Shortens Repolarization in Patients with Sustained Inward Sodium Current Due to Type‐3 Long‐QT SyndromeJournal of Cardiovascular Electrophysiology, 19
-
R. Létienne, B. Vié, A. Puech, S. Vieu, B. Grand, G. John (2001)
Evidence that ranolazine behaves as a weak β1- and β2-adrenoceptor antagonist in the rat cardiovascular systemNaunyn-Schmiedeberg's Archives of Pharmacology, 363
-
W. Hayashida, C. Eyll, M. Rousseau, H. Pouleur (1994)
Effects of ranolazine on left ventricular regional diastolic function in patients with ischemic heart diseaseCardiovascular Drugs and Therapy, 8
-
C. Antzelevitch, A. Burashnikov, S. Sicouri, L. Belardinelli (2011)
Electrophysiologic basis for the antiarrhythmic actions of ranolazine.Heart rhythm, 8 8
-
C. Jacobshagen, L. Belardinelli, G. Hasenfuss, L. Maier (2011)
Ranolazine for the Treatment of Heart Failure With Preserved Ejection Fraction: Background, Aims, and Design of the RALI‐DHF StudyClinical Cardiology, 34
-
G. Antoons, A. Oros, J. Beekman, M. Engelen, M. Houtman, L. Belardinelli, M. Štengl, M. Vos (2010)
Late na(+) current inhibition by ranolazine reduces torsades de pointes in the chronic atrioventricular block dog model.Journal of the American College of Cardiology, 55 8
-
M. Vassalle, Cheng-I. Lin (2004)
Calcium Overload and Cardiac FunctionJournal of Biomedical Science, 11
-
C. Antzelevitch, L. Belardinelli, A. Zygmunt, A. Burashnikov, J. Diego, J. Fish, J. Cordeiro, G. Thomas (2004)
Electrophysiological Effects of Ranolazine, a Novel Antianginal Agent With Antiarrhythmic PropertiesCirculation, 110
-
B. Scirica, E. Braunwald, L. Belardinelli, C. Hedgepeth, J. Špinar, Whedy Wang, J. Qin, E. Karwatowska-Prokopczuk, F. Verheugt, D. Morrow (2010)
Relationship Between Nonsustained Ventricular Tachycardia After Non–ST-Elevation Acute Coronary Syndrome and Sudden Cardiac Death: Observations From the Metabolic Efficiency With Ranolazine for Less Ischemia in Non–ST-Elevation Acute Coronary Syndrome–Thrombolysis in Myocardial Infarction 36 (MERLINCirculation, 122
-
L. Belardinelli, C. Antzelevitch, M. Vos (2003)
Assessing predictors of drug-induced torsade de pointes.Trends in pharmacological sciences, 24 12
-
S. Sicouri, A. Burashnikov, L. Belardinelli, C. Antzelevitch (2010)
Synergistic Electrophysiologic and Antiarrhythmic Effects of the Combination of Ranolazine and Chronic Amiodarone in Canine AtriaCirculation: Arrhythmia and Electrophysiology, 3
-
T. Kiyosue, M. Arita (1989)
Late Sodium Current and Its Contribution to Action Potential Configuration in Guinea Pig Ventricular MyocytesCirculation Research, 64
-
C. Pepine, Wolff Aa (1999)
A controlled trial with a novel anti-ischemic agent, ranolazine, in chronic stable angina pectoris that is responsive to conventional antianginal agents. Ranolazine Study Group.The American journal of cardiology, 84 1
-
N. Wenger, B. Chaitman, G. Vetrovec (2007)
Gender comparison of efficacy and safety of ranolazine for chronic angina pectoris in four randomized clinical trials.The American journal of cardiology, 99 1
-
Sandra Fredj, K. Sampson, Huajun Liu, R. Kass (2006)
Molecular basis of ranolazine block of LQT‐3 mutant sodium channels: evidence for site of actionBritish Journal of Pharmacology, 148
-
A. Burashnikov, S. Sicouri, J. Diego, L. Belardinelli, C. Antzelevitch (2010)
Synergistic effect of the combination of ranolazine and dronedarone to suppress atrial fibrillation.Journal of the American College of Cardiology, 56 15
-
B. Chaitman, C. Pepine, J. Parker, Jaroslav Skopal, G. Chumakova, J. Kuch, Whedy Wang, S. Skettino, A. Wolff (2004)
Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.JAMA, 291 3
-
Zhenghang Zhao, N. Fefelova, M. Shanmugam, P. Bishara, G. Babu, Lai-Hua Xie (2011)
Angiotensin II induces afterdepolarizations via reactive oxygen species and calmodulin kinase II signaling.Journal of molecular and cellular cardiology, 50 1
-
WE Boden, RA O’Rourke, KK Teo, PM Hartigan, DJ Maron, WJ Kostuk (2007)
Optimal medical therapy with or without PCI for stable coronary diseaseN Engl J Med, 356
-
A. Burashnikov, J. Diego, A. Zygmunt, L. Belardinelli, C. Antzelevitch (2007)
Atrium-Selective Sodium Channel Block as a Strategy for Suppression of Atrial Fibrillation: Differences in Sodium Channel Inactivation Between Atria and Ventricles and the Role of RanolazineCirculation, 116
-
N. Fragakis, K. Koskinas, D. Katritsis, E. Pagourelias, T. Zografos, P. Geleris (2012)
Comparison of effectiveness of ranolazine plus amiodarone versus amiodarone alone for conversion of recent-onset atrial fibrillation.The American journal of cardiology, 110 5
-
P. Mehta, P. Goykhman, L. Thomson, Janet Wei, Yuching Yang, E. Gill, M. Minissian, Leslee Shaw, P. Slomka, MD Shufelt, MD Slivka, MD Berman, C. Noel, MD Merz (2011)
Ranolazine improves angina in women with evidence of myocardial ischemia but no obstructive coronary artery disease.JACC. Cardiovascular imaging, 4 5
-
G. Bleeker, Jeroen Bax, P. Steendijk, M. Schalij, E. Wall (2006)
Left ventricular dyssynchrony in patients with heart failure: pathophysiology, diagnosis and treatmentNature Clinical Practice Cardiovascular Medicine, 3
-
Ilanit Itzhaki, L. Maizels, I. Huber, L. Zwi-Dantsis, O. Caspi, Aaron Winterstern, Oren Feldman, A. Gepstein, G. Arbel, H. Hammerman, M. Boulos, L. Gepstein (2011)
Modelling the long QT syndrome with induced pluripotent stem cellsNature, 471
-
C. Mannheimer, P. Camici, M. Chester, A. Collins, M. Dejongste, T. Eliasson, F. Follath, I. Hellemans, J. Herlitz, T. Lüscher, M. Pasic, Dag Thelle (2002)
The problem of chronic refractory angina; report from the ESC Joint Study Group on the Treatment of Refractory Angina.European heart journal, 23 5
-
N. Boulé, Ma, Elizabeth Haddad, G. Kenny, George Wells, R. Sigal (2002)
Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta‐analysis of controlled clinical trialsScandinavian Journal of Medicine & Science in Sports, 12
-
Wei-qun Wang, Chelsea Robertson, A. Dhalla, L. Belardinelli (2008)
Anti-Torsadogenic Effects of Ranolazine in Anesthetized Rabbits -
T. Bunch, S. Mahapatra, D. Murdock, Jamie Molden, J. Weiss, H. May, T. Bair, KATY Mader, B. Crandall, J. Day, Jeffrey Osborn, J. Muhlestein, D. Lappé, Jeffrey Anderson (2011)
Ranolazine Reduces Ventricular Tachycardia Burden and ICD Shocks in Patients with Drug‐Refractory ICD ShocksPacing and Clinical Electrophysiology, 34
-
WQ Wang, C Robertson, AK Dhalla, L Belardinelli (2008)
Antitorsadogenic effects of ({+/−})-N-(2,6-dimethyl-phenyl)-(4[2-hydroxy-3-(2-methoxyphenoxy)propyl]-1-pipera zine (ranolazine) in anesthetized rabbitsJ Pharmacol Exp Ther, 325
-
D. Morrow, B. Scirica, E. Karwatowska-Prokopczuk, S. Murphy, A. Budaj, S. Varshavsky, A. Wolff, A. Skene, C. Mccabe, E. Braunwald (2007)
Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial.JAMA, 297 16
-
L. Maier, R. Wachter, F. Edelmann, B. Layug, E. Karwatowska-Prokopczuk, L. Belardinelli, G. Hasenfuss, C. Jacobshagen (2012)
RANOLAZINE FOR THE TREATMENT OF DIASTOLIC HEART FAILURE IN PATIENTS WITH PRESERVED EJECTION FRACTION: RESULTS FROM THE RALI-DHF STUDYJournal of the American College of Cardiology, 59
-
Yuzhi Wu, Yejia Song, L. Belardinelli, J. Shryock (2009)
The Late Na+ Current (INa) Inhibitor Ranolazine Attenuates Effects of Palmitoyl-L-Carnitine to Increase Late INa and Cause Ventricular Diastolic DysfunctionJournal of Pharmacology and Experimental Therapeutics, 330
-
L. Belardinelli, J. Shryock, H. Fraser (2006)
Inhibition of the late sodium current as a potential cardioprotective principle: effects of the late sodium current inhibitor ranolazineHeart, 92
-
R. Venkataraman, L. Belardinelli, B. Blackburn, J. Heo, A. Iskandrian (2009)
A study of the effects of ranolazine using automated quantitative analysis of serial myocardial perfusion images.JACC. Cardiovascular imaging, 2 11
-
D. Morrow, B. Scirica, B. Chaitman, Darren Mcguire, S. Murphy, E. Karwatowska-Prokopczuk, C. Mccabe, E. Braunwald (2009)
Evaluation of the Glycometabolic Effects of Ranolazine in Patients With and Without Diabetes Mellitus in the MERLIN-TIMI 36 Randomized Controlled TrialCirculation, 119
-
Antianginal Efficacy of Ranolazine When Added to Treatment with Amlodipine the Erica (efficacy of Ranolazine in Chronic Angina) Trial -
Norishige Morita, Jong Lee, Yuanfang Xie, A. Sovari, Z. Qu, J. Weiss, H. Karagueuzian (2011)
Suppression of re-entrant and multifocal ventricular fibrillation by the late sodium current blocker ranolazine.Journal of the American College of Cardiology, 57 3
-
Lin Wu, J. Shryock, Yejia Song, Yuan Li, C. Antzelevitch, L. Belardinelli (2004)
Antiarrhythmic Effects of Ranolazine in a Guinea Pig in Vitro Model of Long-QT SyndromeJournal of Pharmacology and Experimental Therapeutics, 310
-
C. Antzelevitch, J. Fish (2001)
Electrical heterogeneity within the ventricular wallBasic Research in Cardiology, 96
-
D. Noble, P. Noble (2006)
Late sodium current in the pathophysiology of cardiovascular disease: consequences of sodium–calcium overloadHeart, 92
-
D. Murdock, J. Kaliebe, N. Overton (2008)
Ranolozine‐Induced Suppression of Ventricular Tachycardia in a Patient with Nonischemic Cardiomyopathy: A Case ReportPacing and Clinical Electrophysiology, 31
-
Brendan Clarke, Katrina Wyatt, James McCormack (1996)
Ranolazine increases active pyruvate dehydrogenase in perfused normoxic rat hearts: evidence for an indirect mechanism.Journal of molecular and cellular cardiology, 28 2
-
Gong Zhao, Erin Walsh, J. Shryock, E. Messina, Yuzhi Wu, D. Zeng, Xiaobin Xu, M. Ochoa, S. Baker, T. Hintze, L. Belardinelli (2011)
Antiadrenergic and Hemodynamic Effects of Ranolazine in Conscious DogsJournal of Cardiovascular Pharmacology, 57
-
D. Murdock, M. Kersten, J. Kaliebe, G. Larrain (2009)
The Use Of Oral Ranolazine To Convert New Or Paroxysmal Atrial Fibrillation: A Review Of Experience With Implications For Possible "Pill In The Pocket" Approach To Atrial FibrillationIndian Pacing and Electrophysiology Journal, 9
- Publisher
- Springer Journals
- Copyright
- Copyright © 2013 by Springer International Publishing Switzerland
- Subject
- Medicine & Public Health; Cardiology; Pharmacotherapy; Pharmacology/Toxicology
- ISSN
- 1175-3277
- eISSN
- 1179-187X
- DOI
- 10.1007/s40256-012-0003-2
- pmid
- 23335347
- Publisher site
- See Article on Publisher Site
Abstract
Ranolazine is currently approved for use in chronic angina. The basis for this use is likely related to inhibition of late sodium channels with resultant beneficial downstream effects. Randomized clinical trials have demonstrated an improvement in exercise capacity and reduction in angina episodes with ranolazine. This therapeutic benefit occurs without the hemodynamic effects seen with the conventional antianginal agents. The inhibition of late sodium channels as well as other ion currents has a central role in the potential use of ranolazine in ischemic heart disease, arrhythmias, and heart failure. Despite its QTc-prolonging action, albeit minimal, clinical data have not shown a predisposition to torsades de pointes, and the medication has shown a reasonable safety profile even in those with structural heart disease. In this article we present the experimental and clinical data that support its current therapeutic role, and provide insight into potential future clinical applications.
Journal
American Journal of Cardiovascular Drugs – Springer Journals
Published: Jan 19, 2013